Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.

× No keyword cloud information.

6 in total

1. An Herbal Product Alleviates Bleomycin-Induced Pulmonary Fibrosis in Mice via Regulating NF-κB/TNF-α Signaling in Macrophages.

Authors: Fei Jing; Xi Chen; Jingbo Xue; Kai Huang; Feng Xing; Xudong Hu; Yuan Peng; Chenghai Liu
Journal: Front Pharmacol Date: 2022-04-25 Impact factor: 5.988

Review 2. Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Authors: Nadim Srour; Bernard Thébaud
Journal: Stem Cells Transl Med Date: 2015-10-22 Impact factor: 6.940

Review 3. Bispecific antibodies and their applications.

Authors: Gaowei Fan; Zujian Wang; Mingju Hao; Jinming Li
Journal: J Hematol Oncol Date: 2015-12-21 Impact factor: 17.388

4. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.

Authors: Laura Lucarini; Mariaconcetta Durante; Cecilia Lanzi; Alessandro Pini; Giulia Boccalini; Laura Calosi; Flavio Moroni; Emanuela Masini; Guido Mannaioni
Journal: J Cell Mol Med Date: 2016-10-04 Impact factor: 5.310

5. Sodium Houttuyfonate Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice.

Authors: Yun-Hui Shen; Ming-Han Cheng; Xin-Yu Liu; De-Wei Zhu; Jian Gao
Journal: Front Pharmacol Date: 2021-02-25 Impact factor: 5.810

Review 6. Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease.

Authors: Dinesh Khanna; Donald P Tashkin; Christopher P Denton; Martin W Lubell; Cristina Vazquez-Mateo; Stephen Wax
Journal: Rheumatology (Oxford) Date: 2019-04-01 Impact factor: 7.580

6 in total